Saliha Nafil is a Lead Scientist at Frezent Biological Solutions, bringing expertise in cancer biology and preclinical research. She holds a master’s in biotechnology from the City University of New York (CSI) and an MS in Environmental Engineering and Health from UCD-Morocco. During her time at CUNY, Saliha's thesis research focused on investigating the anticancer properties of bioactive compounds derived from microalgae. Before joining Frezent in 2022, Saliha worked as a Research Scientist at the National Institute of Fisheries Research in Morocco. At Frezent, Saliha plays a key role in driving the company's R&D efforts. She contributes her knowledge in oncology research to advance preclinical studies aimed at developing novel cancer therapies.